Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,823 | 143 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $480.54 | 66 | $0 (2019) |
| TerSera Therapeutics LLC | $326.10 | 19 | $0 (2024) |
| Purdue Pharma L.P. | $231.78 | 15 | $0 (2017) |
| Flexion Therapeutics, Inc. | $196.02 | 5 | $0 (2019) |
| Daiichi Sankyo Inc. | $111.52 | 8 | $0 (2019) |
| Medtronic USA, Inc. | $90.58 | 4 | $0 (2020) |
| Allergan, Inc. | $40.37 | 3 | $0 (2020) |
| Takeda Pharmaceuticals America, Inc. | $36.54 | 4 | $0 (2017) |
| Vertos Medical, Inc. | $36.35 | 1 | $0 (2018) |
| Nalu Medical, Inc. | $33.72 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $68.37 | 4 | TerSera Therapeutics LLC ($30.13) |
| 2023 | $75.74 | 4 | TerSera Therapeutics LLC ($75.74) |
| 2022 | $94.96 | 5 | TerSera Therapeutics LLC ($44.24) |
| 2021 | $68.27 | 4 | TerSera Therapeutics LLC ($30.99) |
| 2020 | $158.73 | 8 | Medtronic USA, Inc. ($69.30) |
| 2019 | $337.10 | 15 | Flexion Therapeutics, Inc. ($176.75) |
| 2018 | $412.88 | 42 | PFIZER INC. ($230.04) |
| 2017 | $606.52 | 61 | PFIZER INC. ($238.97) |
All Payment Transactions
143 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/29/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: PAIN MANAGEMENT | ||||||
| 03/20/2024 | TerSera Therapeutics LLC | Prialt (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Pain Management | ||||||
| 01/17/2024 | TerSera Therapeutics LLC | Prialt (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Pain Management | ||||||
| 11/08/2023 | TerSera Therapeutics LLC | Prialt (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Pain Management | ||||||
| 10/04/2023 | TerSera Therapeutics LLC | Prialt (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Pain Management | ||||||
| 08/23/2023 | TerSera Therapeutics LLC | Prialt (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Pain Management | ||||||
| 06/28/2023 | TerSera Therapeutics LLC | Prialt (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Pain Management | ||||||
| 11/30/2022 | TerSera Therapeutics LLC | Prialt (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Pain Management | ||||||
| 10/19/2022 | TerSera Therapeutics LLC | Prialt (Drug) | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: Pain Management | ||||||
| 05/10/2022 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Pain Management | ||||||
| 04/09/2022 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Pain Management | ||||||
| 01/20/2022 | GRT US Holding, Inc. | Qutenza (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Pain Management | ||||||
| 10/20/2021 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Endocrinology | ||||||
| 09/01/2021 | TerSera Therapeutics LLC | Prialt (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Pain Management | ||||||
| 06/03/2021 | RedHill Biopharma Inc. | Movantik (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: Opioid Antagonist | ||||||
| 04/28/2021 | TerSera Therapeutics LLC | Prialt (Drug) | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: Pain Management | ||||||
| 12/27/2020 | Stryker Corporation | IVS - MULTIGEN RF (Device) | Food and Beverage | Cash or cash equivalent | $23.96 | General |
| Category: INTERVENTIONAL SPINE | ||||||
| 11/18/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: HYPERHYDROSIS | ||||||
| 10/19/2020 | Medtronic USA, Inc. | INTELLIS (Device) | Food and Beverage | In-kind items and services | $56.47 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/08/2020 | Medtronic USA, Inc. | INTELLIS (Device) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 08/14/2020 | TerSera Therapeutics LLC | PRIALT (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: PAIN | ||||||
| 08/11/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: HYPERHYDROSIS | ||||||
| 02/20/2020 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: Neuroscience | ||||||
| 02/18/2020 | Nevro Corp. | Senza Spinal Cord Stimulation System (Device) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Spinal Cord Stimulator | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 344 | 649 | $186,755 | $37,532 |
| 2022 | 11 | 503 | 1,009 | $363,148 | $61,500 |
| 2021 | 14 | 629 | 1,250 | $436,290 | $74,347 |
| 2020 | 18 | 901 | 1,786 | $782,863 | $105,076 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 117 | 233 | $36,781 | $16,208 | 44.1% |
| 62370 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | Facility | 2023 | 67 | 192 | $38,208 | $6,368 | 16.7% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 20 | 28 | $35,200 | $4,274 | 12.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 56 | 80 | $8,480 | $3,518 | 41.5% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 19 | 26 | $12,896 | $2,560 | 19.9% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 19 | 25 | $11,400 | $1,412 | 12.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 15 | 15 | $3,750 | $1,336 | 35.6% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 20 | 28 | $36,300 | $1,325 | 3.7% |
| 62368 | Electronic analysis and reprogramming of spinal canal drug infusion pump | Facility | 2023 | 11 | 22 | $3,740 | $530.88 | 14.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 111 | 236 | $25,916 | $10,679 | 41.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 86 | 142 | $22,694 | $9,771 | 43.1% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2022 | 47 | 92 | $45,632 | $9,120 | 20.0% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2022 | 37 | 56 | $61,600 | $8,974 | 14.6% |
| 62370 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | Facility | 2022 | 76 | 250 | $49,750 | $8,332 | 16.7% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2022 | 47 | 92 | $41,952 | $5,249 | 12.5% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2022 | 38 | 57 | $81,400 | $2,823 | 3.5% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Facility | 2022 | 12 | 21 | $14,536 | $2,425 | 16.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 24 | 24 | $6,000 | $2,290 | 38.2% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Facility | 2022 | 12 | 21 | $10,608 | $1,372 | 12.9% |
| 62368 | Electronic analysis and reprogramming of spinal canal drug infusion pump | Facility | 2022 | 13 | 18 | $3,060 | $464.90 | 15.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 149 | 300 | $33,375 | $13,640 | 40.9% |
| 62370 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | Facility | 2021 | 101 | 327 | $65,073 | $11,200 | 17.2% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance | Facility | 2021 | 39 | 55 | $61,600 | $10,823 | 17.6% |
| 64493 | Injections of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2021 | 46 | 91 | $44,640 | $8,768 | 19.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 86 | 126 | $20,782 | $8,701 | 41.9% |
About Dr. John Larson, MD
Dr. John Larson, MD is a Interventional Pain Medicine healthcare provider based in Batesville, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104864354.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Larson, MD has received a total of $1,823 in payments from pharmaceutical and medical device companies, with $68.37 received in 2024. These payments were reported across 143 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($1,823).
As a Medicare-enrolled provider, Larson has provided services to 2,377 Medicare beneficiaries, totaling 4,694 services with total Medicare billing of $278,456. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Interventional Pain Medicine
- Other Specialties Anesthesiology, Pain Medicine
- Location Batesville, AR
- Active Since 06/02/2006
- Last Updated 05/14/2024
- Taxonomy Code 208VP0014X
- Entity Type Individual
- NPI Number 1104864354
Products in Payments
- LYRICA (Drug) $405.39
- Prialt (Drug) $204.73
- Zilretta (Drug) $196.02
- PRIALT (Drug) $145.00
- OXYCONTIN (Drug) $81.73
- INTELLIS (Device) $69.30
- Movantik (Drug) $68.18
- Morphabond ER (Drug) $62.75
- EMBEDA (Drug) $60.53
- HYSINGLA ER (Drug) $59.92
- BOTOX (Biological) $56.43
- Amitiza (Drug) $36.54
- mild Device Kit (Device) $36.35
- Nalu Neurostimulation System (Device) $33.72
- IVS - MULTIGEN RF (Device) $23.96
- QUTENZA (Drug) $22.18
- Tymlos (Biological) $17.87
- Qutenza (Drug) $17.00
- NEOX (Biological) $16.07
- BUTRANS (Drug) $15.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.